The Journal of Clinical Pharmacology Monthly Journal CE Activities

For more than 50 years, The Journal of Clinical Pharmacology (JCP), ACCP’s flagship journal, has focused on exceptional, peer-reviewed articles that span the breadth of research and drug development to clinical care and include original research, educational series and editorials. ACCP now offers online Continuing Medical Education (CME) and Continuing Pharmacy Education (CPE) credits for select JCP articles each month. The JCP CME and CPE activities are available for free for Members and $75/calendar year for Non-members.

A listing of recent articles that offer CE credit is below. Click on the article title to register for the activity. Each activity includes a copy of the article, a post-event test and an evaluation. CE Certificates are available after the learner scores 75% or better on the activity post-event test. CPE data is uploaded into the CPE Monitor. For best visual quality, we recommend viewing the Journal CE in the Chrome browser. If you do not have Chrome, you can download it here.

JCP Journal CE articles are priced in packages of Jan - Dec for each year. Packages are available at no cost to ACCP Members and $75/calendar year to Non-members. Once you register, you have access to all of the articles for the calendar year.

If you have an ACCP profile, make sure you have signed in to the ACCP website and then Register. If you do not have an ACCP profile, one must be created before you can Register for Journal CE articles. If you do not know if you have a profile, please contact [email protected] for further information to avoid creating duplicate profiles. Once you have registered, you can access articles under the "Article" tab.

Register & Access Journal CEs from 2026 Expires January 31, 2030 

June 2026 - Evaluation of Vancomycin Dosing Practices in Critically Ill Patients Receiving Accelerated Venovenous Hemofiltration 1 CME or CPE

May 2026 - Assessment of the Drug–Drug Interaction Potential of Lotiglipron (PF-07081532) with Midazolam,Omeprazole,Dabigatran, Rosuvastatin,and the Oral Contraceptives Levonorgestrel and Ethinyl Estradiol 1 CME or CPE

April 2026 - Learnings from Approved Antibody-Drug Conjugates: Clinical Pharmacology Perspectives 1 CME or CPE

March 2026 - Construction and Validation of a Predictive Model for the Risk of Anti-Tuberculosis Drug-Induced Liver Injury Based on Machine Learning Algorithms 1 CME or CPE

February 2026 - Physiologically Based Pharmacokinetic Modeling of Oxcarbazepine to Characterize Its Disposition in Children with Obesity 1 CME or CPE

January 2026 - A Phase 1 Randomized Study: Garadacimab Pharmacokinetics, Safety, and Tolerability After Administration via Autoinjector/Pre-Filled Pen Versus Pre-Filled Syringe in Healthy Participants 1 CME or CPE

Register & Access Journal CEs from 2025 Expires January 31, 2029 

December 2025 - Reversal of Fentanyl-Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene Administered by Auto-Injector Versus Intranasal Naloxone 1 CME or CPE credit 

November 2025 - Pharmacokinetic Characterization of Iopamidol and Iohexol for Optimizing Measured Glomerular Filtration Rate Assessment in Clinical Practice and Drug Development  1 CME or CPE credit 

October 2025 - Population Pharmacokinetics and Exposure–Response Relationships of Etrolizumab in Patients with Moderately‐to‐Severely Active Crohn's Disease 1 CME or CPE credit 

September 2025 - Evaluation of Risk Factors for Supratherapeutic Anti‐Xa Levels with Treatment‐Dose Enoxaparin in Hospitalized Patients Without Severe Renal Impairment  1 CME or CPE credit 

August 2025 - The Effects of the Early and Late Phases of Septic Shock on the Population Pharmacokinetics of Vancomycin 1 CME or CPE credit 

July 2025 - Pharmacokinetics and Safety of Fenofibrate in Participants with Mild Hepatic Impairment or with Advanced Fibrosis due to Metabolic‐Associated Fatty Liver Disease 1 CME or CPE credit

June 2025 -  Are Exposure Recommendations for QT Evaluation Being Fulfilled? 1 CME or CPE credit

 May 2025 - Characterization of Renal OAT3 and Hepatic CYP3A Activities in Pregnant Women with Acute Pyelonephritis Using the Endogenous Biomarker Cortisol and 6β‐Hydroxycortisol 1 CME or CPE credit

April 2025 -   Population Pharmacokinetic Simulations for Dose Optimization of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients with Moderate‐to‐Severe Renal Impairment 1 CME or CPE credit

March 2025 - Subclinical Hyperthyroidism Enhances Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women 1 CME or CPE credit

February 2025 - Pharmacokinetics of Ganaplacide and Lumefantrine in Adults, Adolescents, and Children with Plasmodium falciparum Malaria Treated with Ganaplacide Plus Lumefantrine Solid Dispersion Formulation: Analysis of Data from a Multinational Phase 2 Study 1 CME or CPE credit

January 2025 - A Model-Based Approach Supporting Abacavir/Dolutegravir/Lamivudine Fixed-Dose Combination Approval in Children Living with HIV-1 1 CME or CPE credit

Register & Access Journal CEs from 2024 Expires 12/31/2027

December 2024 - Pharmacokinetics of Dexamethasone in Children and Adolescents with Obesity  1 CME or CPE credit

November 2024 - Clinical Characteristics of Moxifloxacin-Related Arrhythmias and Development of a Predictive Nomogram: A Case Control Study 1 CME or CPE credit

October 2024 -  Development and Evaluation of Ontogeny Functions of the Major UDP-Glucuronosyltransferase Enzymes to Underwrite Physiologically Based Pharmacokinetic Modeling in Pediatric Populations 1 CME or CPE credit

September 2024 - Prediction of Pediatric Pharmacokinetics for CYP3A4 Metabolized Drugs: Comparison of the Performance of Two Hepatic Ontogeny Within a Physiologically Based Pharmacokinetic Model 1 CME or CPE credit

July 2024 - Pharmacokinetics-Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study 1 CME or CPE credit

June 2024 - Phenibut: Review and Pharmacologic Approaches to Treating Withdrawal 1 CME or CPE credit

May 2024 - Cannabis Science and Therapeutics: An Overview for Clinicians 1 CME or CPE credit

April 2024 - Prognostic Impact of Early Administration of ß-Blockers in Critically Ill Patients with Acute Myocardial Infarction 1 CME or CPE credit

March 2024 - Urate-Lowering Drugs and Muscle Injury: A Systematic Review and Network Meta-Analysis 1 CME or CPE credit

February 2024 - Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID-19 1 CME or CPE credit

January 2024 - The Influence of a Therapeutic Drug Monitoring Service on Vancomycin-Associated Nephrotoxicity 1 CME or CPE credit